#303: The AI Stocks No One is Talking About: Biotech Boom
This week, Emmet and Mike are digging into one of the hottest trends of our futuristic world: human longevity. We’ve all seen Bryan Johnson on our social feeds, but the business of living longer is more than just a meme. Today, new-age pharmaceutical companies are leveraging AI to reinvent the drug development…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Stock Club
See all episodes →Chapters Group: Europe's Mini Constellation Software With Compounding Quality's Pieter Slegers
Ouster & Schaeffler: Two More Investicon Stock Picks, One Year Later | Stock Club 323
Two Overlooked AI Stocks Worth Knowing About
Similar episodes from other shows
More like Stock Club →
Longevity: Can We Add Another 30 Years? | The Decade Ahead
CRISPR, Gene Therapies, and Cure Pricing Conundrums
Financial Expert: 5 Stocks Under $100 That Could Make You Rich By 2030 (Buy TODAY!)
EP 27: AI Revolutionizing Drug Discovery (2023 - 2025)
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.